Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients

Por Ménard, A, Dhiver, C, Ravaux, I, Moreau, J, Mokhtari, S, Colson, P, Meddeb, L, Brouqui, P, Stein, A
Publicado no BMC Infect Dis (2014)